Suppressing Inflammation for the Treatment of Diabetic Retinopathy and Age-Related Macular Degeneration: Dazdotuftide as a Potential New Multitarget Therapeutic Candidate

Suppressing Inflammation for the Treatment of Diabetic Retinopathy and Age-Related Macular Degeneration: Dazdotuftide as a Potential New Multitarget Therapeutic Candidate

Diabetic retinopathy (DR) and age-related macular degeneration (AMD) are major causes of blindness globally. The primary treatment option for DME and neovascular AMD (nAMD) is anti-vascular endothelial growth factor (VEGF) compounds, but this treatment modality often yields insufficient results, and...

Bibliografski detalji
Glavni autori:	Brice Nguedia Vofo, Itay Chowers
Format:	Članak
Jezik:	English
Izdano:	MDPI AG 2023-05-01
Serija:	Biomedicines
Teme:	diabetic retinopathy diabetic macula edema age related macular degeneration anti-inflammatory compounds anti-vascular endothelial growth factor dazdotuftide
Online pristup:	https://www.mdpi.com/2227-9059/11/6/1562

Slični predmeti

Macular oedema as manifestation of diabetic retinopathy
od: Mukharram M. Bikbov, i dr.
Izdano: (2017-10-01)

Artificial intelligence algorithms for the diagnosis of signs of diabetic retinopathy, diabetic macular edema, age-related macular degeneration, vitreomacular interface abnormalities
od: E.A. Katalevskaya, i dr.
Izdano: (2022-12-01)

Bibliometric and visualized analysis of diabetic macular edema
od: Jin Wei, i dr.
Izdano: (2024-01-01)

The results of diagnostic and treatment of patients with diabetic retinopathy and age-related macular degeneration at a diabetes type 2.
od: I. V. Vorobyova, i dr.
Izdano: (2014-10-01)

Relationship between Diabetic Nephropathy and Development of Diabetic Macular Edema in Addition to Diabetic Retinopathy
od: Yukihisa Suzuki, i dr.
Izdano: (2023-05-01)

Effect of anti-vascular endothelial growth factor on early-stage post-vitrectomy macular edema in patients with proliferative diabetic retinopathy
od: Hantao Zhou, i dr.
Izdano: (2024-09-01)

Aspirin intake is not associated with diabetic retinopathy and diabetic macular edema: A report from the Fushun diabetic retinopathy cohort study
od: Wei Lin, i dr.
Izdano: (2024-01-01)

A study of therapeutic effects of 670 nm irradiation in different types of diabetic macular edema
od: S. Ramin, i dr.
Izdano: (2021-02-01)

Prevention of macular edema and secondary degeneration of the macula and posterior pole in anterior uveitis
od: N.V. Konovalova, i dr.
Izdano: (2019-04-01)

Evaluation of Macular Thickness Changes after Uncomplicated Phacoemulsification Surgery in Healthy Subjects and Diabetic Patients without Retinopathy by Spectral Domain OCT
od: Mikel García Gómez de Segura, i dr.
Izdano: (2022-12-01)

Intravitreal Antiangiogenic Treatment for Diabetic Retinopathy: A Mexican Real-Life Scenario Experience
od: Sonia López-Letayf, i dr.
Izdano: (2024-08-01)

Oxidative Stress and Its Regulation in Diabetic Retinopathy
od: Cameron D. Haydinger, i dr.
Izdano: (2023-08-01)

The Association of Intravitreal Anti-VEGF Injections With Kidney Function in Diabetic Retinopathy
od: Casey C. Bunge, MD, i dr.
Izdano: (2023-12-01)

Functional results one-year following the anti-VEGF therapy in macular pathology
od: Nicoleta Anton, i dr.
Izdano: (2023-12-01)

Stroke incidence increases with diabetic retinopathy severity and macular edema in type 1 diabetes
od: Marika I Eriksson, i dr.
Izdano: (2024-04-01)

Comparison Of Intravitreal Triamcinolone Injection Vs Laser Photocoagulation in Angiographic Macular Edema in Diabetic Retinopathy
od: Somesh V Aggarwal, i dr.
Izdano: (2012-09-01)

Response of Diabetic Macular Edema to Anti-VEGF Medications Correlates with Improvement in Macular Vessel Architecture Measured with OCT Angiography
od: Michael T. Massengill, MD, PhD, i dr.
Izdano: (2024-07-01)

Diabetic macular edema (DME): dissecting pathogenesis, prognostication, diagnostic modalities along with current and futuristic therapeutic insights
od: Ahmed Sermed Al Sakini, i dr.
Izdano: (2024-10-01)

Deep Learning Prediction of Response to Anti-VEGF among Diabetic Macular Edema Patients: Treatment Response Analyzer System (TRAS)
od: Saif Aldeen Alryalat, i dr.
Izdano: (2022-01-01)

Does epigenetics have a role in age related macular degeneration and diabetic retinopathy?
od: S. Mohana Devi, i dr.
Izdano: (2021-05-01)

Role of inhibition of angiogenesis in patients with diabetic retinopathy
od: E.S. Chekhonin, i dr.
Izdano: (2022-12-01)

Dexamethasone implant for refractory macular edema secondary to diabetic retinopathy and retinal vein occlusion
od: Yuan-Yuan Zhong, i dr.
Izdano: (2024-10-01)

Clinical Evaluation of Faricimab in Real-World Diabetic Macular Edema in India- A Multicenter Observational Study
od: Chakraborty D, i dr.
Izdano: (2025-01-01)

Optical Coherence Tomography Biomarkers Predict the Long-Term Restorative Effect of Early Anti-VEGF Treatment on Diabetic Macular Edema
od: Süleyman Okudan, i dr.
Izdano: (2025-02-01)

Ultrastructural imaging biomarkers in diabetic macular edema: A major review
od: Sagnik Sen, i dr.
Izdano: (2025-01-01)

miR-145, miR-92a and miR-375 Show Differential Expression in Serum from Patients with Diabetic Retinopathies
od: Adriana Solis-Vivanco, i dr.
Izdano: (2022-09-01)

Biomarkers for diabetic retinopathy
od: Maria V. Budzinskaya, i dr.
Izdano: (2020-04-01)

Real-World Outcomes of Faricimab Treatment for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
od: Quah NQX, i dr.
Izdano: (2024-05-01)

Glaucoma and Diabetic Retinopathy in patients with diabetes mellitus type 2. Review.
od: I. V. Vorobyeva, i dr.
Izdano: (2014-10-01)

OCT and OCT Angiography Update: Clinical Application to Age-Related Macular Degeneration, Central Serous Chorioretinopathy, Macular Telangiectasia, and Diabetic Retinopathy
od: Lyvia Zhang, i dr.
Izdano: (2023-01-01)

Evaluation Of Choroidal Thickness Before and After Intravitreal Injection Of Anti Vascular endothelial growth factors for Treatment Of Diabetic Macular Edema using Optical Coherence Tomography
od: Noha Mahmoud Ahmed Mohamed *, i dr.
Izdano: (2023-07-01)

Impact of anti-VEGF treatment on development of proliferative diabetic retinopathy in routine clinical practice
od: Andrew A. Moshfeghi, i dr.
Izdano: (2024-05-01)

Crocin Monotherapy in Non-Central Diabetic Macular Edema
od: Mojtaba Mojtahedzadeh, i dr.
Izdano: (2024-12-01)

Extending the diabetic retinopathy screening intervals in Singapore: methodology and preliminary findings of a cohort study
od: Amudha Aravindhan, i dr.
Izdano: (2024-03-01)

Rate and Predictors of Misclassification of Active Diabetic Macular Edema as Detected by an Automated Retinal Image Analysis System
od: Lamberto La Franca, i dr.
Izdano: (2024-04-01)

Monitoring of Separate Pathogenetically Significant Biochemical Markers in Lacrimal Fluid, Ophthalmological Parameters with Combined Pathology of Diabetic Retinopathy and Age-Related Macular Degeneration on the Background Angioprotective and Antioxidant Therapy
od: I. V. Vorobyeva
Izdano: (2018-07-01)

Combination therapy of intravitreal ranibizumab and sub-tenon triamcinolone for treatment of resistant diabetic macular edema: a clinical study in Egypt
od: Hossam Eldin M. A. Khalil, i dr.
Izdano: (2025-01-01)

Macular changes following cataract surgery in eyes with early diabetic retinopathy: an OCT and OCT angiography study
od: Huiping Yao, i dr.
Izdano: (2023-11-01)

Diabetic Macular Edema: Current Understanding, Molecular Mechanisms and Therapeutic Implications
od: Jingfa Zhang, i dr.
Izdano: (2022-10-01)

Semantic analysis of social media messages of patients with neovascular age-related macular degeneration and diabetic macular edema by open Internet sources — a study of patients' opinions in real clinical practice
od: V. V. Neroev, i dr.
Izdano: (2023-03-01)